|
1
|
Montano-Loza AJ, Thandassery RB and Czaja
AJ: Targeting hepatic fibrosis in autoimmune hepatitis. Dig Dis
Sci. 61:3118–3139. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Czaja AJ: Nature and implications of
oxidative and nitrosative stresses in autoimmune hepatitis. Dig Dis
Sci. 13:122–123. 2016.
|
|
3
|
Yeo SH and Yang CH: Peptic ulcer disease
associated with Helicobacter pylori infection. Korean J
Gastroenterol. 67:289–299. 2016.(In Korean). View Article : Google Scholar : PubMed/NCBI
|
|
4
|
El-Matary W, Dalzell AM and Ashworth M:
Helicobacter pylori and autoimmune hepatitis. Eur J Pediatr.
164:54–55. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Muratori P, Lalanne C, Bianchi G, Lenzi M
and Muratori L: Predictive factors of poor response to therapy in
autoimmune hepatitis. Dig Liver Dis. 48:1078–1081. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Utiyama SR, Zenatti KB, Nóbrega HA, Soares
JZ, Skare TL, Matsubara C, Muzzilo DA and Nisihara RM: Rheumatic
disease autoantibodies in autoimmune liver diseases. Immunol
Invest. 45:566–573. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Muratori L, Deleonardi G, Lalanne C,
Barbato E, Tovoli A, Libra A, Lenzi M, Cassani F and Muratori P:
Autoantibodies in autoimmune hepatitis. Dig Dis. 33 Suppl 2:65–69.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tomizawa M, Shinozaki F, Fugo K, Motoyoshi
Y, Sugiyama T, Yamamoto S, Kishimoto T and Ishige N:
Anti-mitochondrial M2 antibody-positive autoimmune hepatitis. Exp
Ther Med. 10:1419–1422. 2015.PubMed/NCBI
|
|
9
|
Sun L, Wang Y, Liu Y, Zhao Y, Zhang X,
Wang Y, Zhao D, Zhang H and Ma Y: Differential characteristics of
AMA-M2 autoantibody in primary biliary cirrhosis and non-PBC
patients. Zhonghua Gan Zang Bing Za Zhi. 23:343–349. 2015.(In
Chinese). PubMed/NCBI
|
|
10
|
Longhi MS, Mieli-Vergani G and Vergani D:
Autoimmune hepatitis. Curr Pediatr Rev. 10:268–274. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stinton LM, Bentow C, Mahler M, Norman GL,
Eksteen B, Mason AL, Kaplan GG, Lindkvist B, Hirschfield GM,
Milkiewicz P, et al: PR3-ANCA: A promising biomarker in primary
sclerosing cholangitis (PSC). PLoS One. 9:e1128772014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nagai T, Imamura M, Kamiya Y and Mori M:
Graves' disease accompanied by anti-myeloperoxidase
antibody-related nephropathy and autoimmune hepatitis. Intern Med.
43:516–520. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liberal R, Grant CR, Longhi MS,
Mieli-Vergani G and Vergani D: Diagnostic criteria of autoimmune
hepatitis. Autoimmun Rev. 13:435–440. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
An IC, Tiwari AK, Ameda S and Laird-Fick
HS: Autoimmune hepatitis: Diagnostic dilemma in the setting of
suspected iron overload. Case Rep Gastrointest Med.
2013:8729872013.PubMed/NCBI
|
|
15
|
Silva LD, Rocha AM, Rocha GA, de Moura SB,
Rocha MM, Dani R, de Melo FF, Guerra JB, de Castr LP, Mendes GS, et
al: The presence of Helicobacter pylori in the liver depends on the
Th1, Th17 and Treg cytokine profile of the patient. Mem Inst
Oswaldo Cruz. 106:748–754. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mackay IR, Leskovsek NV and Rose NR: Cell
damage and autoimmunity: A critical appraisal. J Autoimmun.
30:5–11. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dzierzanowska-Fangrat K, Nilsson I,
Wozniak M, Jozwiak P, Rozynek E, Woynarowski M, Socha J, Ljungh A
and Wadström T: Lack of an association between Helicobacter
infection and autoimmune hepatitis in children. Pol J Microbiol.
55:157–159. 2006.PubMed/NCBI
|
|
18
|
Vorobjova T, Nilsson I, Terjajev S,
Granholm M, Lyyra M, Porkka T, Prükk T, Salupere R, Maaroos HI and
Wadström T: Serum antibodies to enterohepatic Helicobacter spp. in
patients with chronic liver diseases and in a population with high
prevalence of H. pylori infection. Dig Liver Dis. 38:171–176. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Durazzo M, Pellicano R, Premoli A,
Berrutti M, Leone N, Ponzetto A and Rizzetto M: Helicobacter pylori
seroprevalence in patients with autoimmune hepatitis. Dig Dis Sci.
47:380–383. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Galperin C and Gershwin ME:
Immunopathogenesis of gastrointestinal and hepatobiliary diseases.
JAMA. 278:1946–1955. 1997. View Article : Google Scholar : PubMed/NCBI
|
